Month:

NASDAQ: KMLI Leveraged Daily Exposure to a Single Underlying Stock Through One ETF An exchange-traded fund from KraneShares offering leveraged exposure aligned with MercadoLibre’s daily performance. KraneShares has introduced the KraneShares 2× Long MELI Daily ETF (KMLI), a single-stock leveraged exchange-traded fund designed to seek approximately twice (200%) the daily percentage change of the U.S.-listed… Continue reading A Single-Stock ETF Offering Leveraged Daily Exposure to MercadoLibre

NASDAQ: KBAB A Single ETF Built for Leveraged Daily Exposure to Alibaba A KraneShares exchange-traded fund designed to deliver leveraged exposure to Alibaba’s daily stock movements through a structured ETF format. KraneShares has introduced the KraneShares 2× Long Alibaba Daily ETF (KBAB), a single-stock leveraged exchange-traded fund designed to seek approximately twice (200%) the daily… Continue reading A Single-Stock ETF Offering Leveraged Daily Exposure to Alibaba

NASDAQ: KPDD Leveraged Daily Exposure to PDD Holdings Through a Single ETF An exchange-traded fund from KraneShares designed to provide leveraged exposure to PDD Holdings’ daily stock price movements. KraneShares has introduced the KraneShares 2× Long PDD Daily ETF (KPDD), a single-stock leveraged exchange-traded fund designed to seek approximately twice (200%) the daily percentage change… Continue reading A Single-Stock ETF Offering Leveraged Daily Exposure to PDD Holdings

NASDAQ: SHFS Powering Cannabis Payments: Secure, Compliant Financial Solutions See Why SHF Holdings (NASDAQ: SHFS) Is Drawing Attention Now Chart Website Price Targets $1.55 +25% $2.00 +65.11% $2.23 +79.23% Potential support ~ 1.24 LATEST NEWS Safe Harbor Expands Client Offerings With Cannabis Insurance Solutions Through Partnerships With Frontier Risk and AlphaRoot READ MORE 4 Reasons… Continue reading Safe Harbor Financial: Compliant Banking for the Cannabis Industry

NASDAQ: GTBP Transforming Cancer Treatment Through Next-Generation Immunotherapy Why Now Could Be a Compelling Time to Research GT Biopharma (NASDAQ: GTBP) Chart Website About GT Biopharma, Inc. GT Biopharma, Inc. is a clinical-stage immuno-oncology company focused on developing innovative therapies based on its proprietary NK cell engager (TriKE®) technology. The company’s TriKE® therapeutic agents are… Continue reading A Clinical-Stage Immuno-Oncology Platform Built Around TriKE® Technology